Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Regenerative Medical Technology (RMTG) Shares Outstanding (Weighted Average) (2017 - 2025)

Historic Shares Outstanding (Weighted Average) for Regenerative Medical Technology (RMTG) over the last 9 years, with Q3 2025 value amounting to $12.5 million.

  • Regenerative Medical Technology's Shares Outstanding (Weighted Average) changed 0.0% to $12.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.5 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $12.5 million for FY2024, which is 67.88% up from last year.
  • According to the latest figures from Q3 2025, Regenerative Medical Technology's Shares Outstanding (Weighted Average) is $12.5 million, which was down 0.0% from $12.5 million recorded in Q2 2025.
  • Regenerative Medical Technology's Shares Outstanding (Weighted Average)'s 5-year high stood at $12.5 million during Q3 2024, with a 5-year trough of $10.9 million in Q1 2021.
  • Over the past 5 years, Regenerative Medical Technology's median Shares Outstanding (Weighted Average) value was $12.4 million (recorded in 2023), while the average stood at $12.2 million.
  • Per our database at Business Quant, Regenerative Medical Technology's Shares Outstanding (Weighted Average) skyrocketed by 3059.5% in 2021 and then changed by 0.0% in 2025.
  • Over the past 5 years, Regenerative Medical Technology's Shares Outstanding (Weighted Average) (Quarter) stood at $11.5 million in 2021, then increased by 6.42% to $12.2 million in 2022, then rose by 1.86% to $12.4 million in 2023, then grew by 0.68% to $12.5 million in 2024, then rose by 0.06% to $12.5 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $12.5 million in Q3 2025, compared to $12.5 million in Q2 2025 and $12.5 million in Q1 2025.